Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production ...

Eli Lilly & Company (NYSE:LLY) ranks among the stocks with the best earnings growth for the next 5 years. Cantor Fitzgerald reaffirmed its Overweight rating and $925 price target for Eli Lilly & ...

In today’s ACT Brief, we explore how Eli Lilly’s orforglipron could become the first oral GLP-1 therapy reviewed under FDA’s new national priority program, and examine emerging regulatory and ethical ...

Or how about the drug companies? Holy cow, remember them? They used to be big and important, weren’t they? Eli Lilly reported this morning, and their GLP-1 complex, you know, the weight loss ...

The healthcare industry has proven to be a resilient place for investors to put cash to work over the years. If you are ...

Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central ...

South Korean tech giant Samsung is making a major investment in artificial intelligence by building a factory powered by 50,000 Nvidia GPUs. This AI megafactory, as Samsung calls it, aims to ...

Global pharmaceutical company Pfizer (NYSE:PFE) will be announcing earnings results this Tuesday before market open. Here’s ...

AI use cases now run the gamut. From early cancer detection and digital companionship to helping frustrated readers find ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

Lending platform Pagaya Technologies on Monday announced an agreement to sell up... The owners of the distribution firm behind Irish fake tan brands such as Suzanne... Grant Thornton’s non-audit ...

Virginia will be home to a workforce training center preparing thousands of people each year for a career in the pharmaceutical industry.